COPD exacerbations in general practice: variability in oral prednisolone courses

BMC Primary Care

Table 3 Percentage of GPs adjusting their treatment in case of diabetic co-morbidity

		Case 1		Case 2		Case 3		Case 4
		GOLD 1,2 no severe exacerbation		GOLD 1,2, severe exacerbation		GOLD 3,4, no severe exacerbation		GOLD 3,4, severe exacerbation
	Adjustment:
		N = 162	CI	N = 157	CI	N = 153	CI	N = 154	CI
1.	Higher total treatment dose	1%	[0.001-0.044]	1%	[0.002-0.045]	2%	[0.004-0.056]	0%	[0.000-0.000]
2.	Lower total treatment dose	11%	[0.067-0.170]	14%	[0.090-0.204]	14%	[0.087-0.202]	2%	[0.004-0.056]
3.	No treatment	3%	[0.010-0.071]	0%	[0.000-0.000]	1%	[0.002-0.046]	0%	[0.000-0.000]
4.	Specialist treatment	0%	[0.000-0.000]	5%	[0.022-0.098]	0%	[0.000-0.000]	10%	[0.056-0.156]
	No adjustment:
5.	Both patients same total treatment dose	83%	[0.053- 0.148]	69%	[0.609-0.759]	83%	[0.761-0.886]	25%	[0.187-0.330]
6.	Both patients no treatment	2%	[0.004-0.053]	0%	[0.000-0.000]	0%	[0.000-0.000]	0%	[0.000-0.000]
7.	Both patients specialist line treatment	0%	[0.000-0.000]	11%	[0.064-0.168]	0%	[0.000-0.000]	63%	[0.548-0.706]

ISSN: 2731-4553